Table 2 Number of patients with isolate susceptibility data (number of resistant isolates) linked with epidemiological data, i.e., sexual orientation, age group and concurrent chlamydial infection
| Â | Total number of patient variables (no. resistant) | ||||||
|---|---|---|---|---|---|---|---|
MSM | Male heterosexuals | Females | ≥25 years | <25 years | Concurrent chlamydia | No concurrent chlamydia | |
Azithromycin | 494 (14) | 369 (24) | 302 (16) | 1391 (72) | 553 (35) | 183 (3) | 658 (20) |
Ciprofloxacin | 496 (210) | 376 (209) | 302 (150) | 1399 (769) | 554 (262) | 183 (69) | 658 (307) |
Cefixime | 496 (6) | 376 (23) | 302 (17) | 1399 (68) | 554 (22) | 183 (3) | 658 (13) |